You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (10)

Journals (0)

1-10 of 10 results for CLDN18.2

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Safety and Pharmacokinetic Assessment of the FIC CLDN18.2/4-1BB Bispecific Antibody in Rhesus Monkeys

Free access

Research article

First published 2024-6

Safety and Pharmacokinetic Assessment of the FIC CLDN18.2/4-1BB Bispecific Antibody in Rhesus Monkeys

Jing Wang, Tiantian Dong, Xinjiang Gong [...]

International Journal of Toxicology

Select article: Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer

Open access

Review article

First published 2024

Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer

Yohei Kubota, Kohei Shitara

Therapeutic Advances in Medical Oncology

Select article: Clinicopathological and molecular features of claudin-18 isoform 2 expression in patients with colorectal cancer: a single-center retrospective study

Open access

Research article

First published 2024

Clinicopathological and molecular features of claudin-18 isoform 2 expression in patients with colorectal cancer: a single-center retrospective study

Shigemasa Takamizawa, Hidekazu Hirano, Atsuo Takashima [...]

Therapeutic Advances in Medical Oncology

Select article: First-line treatment with zolbetuximab plus CAPOX for ClDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis

Open access

Research article

First published 2024

First-line treatment with zolbetuximab plus CAPOX for ClDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis

Jianying Lei, Jiahao Zhang, Caicong You [...]

Therapeutic Advances in Gastroenterology

Select article: Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative,proficient MMR,PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer

Open access

Research article

First published 2025

Impact of claudin 18.2 expression on treatment outcomes of first-line immunochemotherapy in patients with HER2-negative,proficient MMR,PD-L1 CPS ⩾1 metastatic gastric/gastroesophageal junction cancer

Fei Zhang, Izuma Nakayama, Naoya Sakamoto [...]

Therapeutic Advances in Medical Oncology

Select article: Zolbetuximab-clzb: Targeting Claudin 18.2 in Advanced Gastric and Gastroesophageal Adenocarcinoma

Retricted access

Review article

First published 2025-12

Zolbetuximab-clzb: Targeting Claudin 18.2 in Advanced Gastric and Gastroesophageal Adenocarcinoma

Gabrielle L. Gorwitz, David L. DeRemer

Annals of Pharmacotherapy

Select article: The dawn of precision medicine in diffuse-type gastric cancer

Open access

Review article

First published 2022

The dawn of precision medicine in diffuse-type gastric cancer

Akira Ooki, Kensei Yamaguchi

Therapeutic Advances in Medical Oncology

Select article: Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond

Open access

Review article

First published 2025

Emerging evidence of targeting non-oncogenic drivers for gastric cancer: Claudin18.2 and beyond

Kazumasa Yamamoto, Izuma Nakayama, Kohei Shitara

Therapeutic Advances in Medical Oncology

Select article: Advancements in targeted therapy for gastric cancer

Open access

Review article

First published 2026

Advancements in targeted therapy for gastric cancer

Yihua Wang, Jie Li, Guanmo Liu [...]

Therapeutic Advances in Gastroenterology

Select article: Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2–Positive,HER2-Negative,Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review

Open access

Research article

First published 2026

Symptom Burden and Healthcare Resource Use in Patients With Claudin 18.2–Positive,HER2-Negative,Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma: A Retrospective Review

Matheus Sewastjanow-Silva, Mok Oh, Lawrence Chang [...]

Clinical Medicine Insights: Oncology

1
10 / page

Article type

Publication date

Subjects

Access